Good afternoon :)
Place Order
Add to Watchlist

Rainbow Children's Medicare Ltd

RAINBOW

Rainbow Children's Medicare Ltd

RAINBOW
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹14,005 cr, stock is ranked 445
Moderate RiskStock is 2.77x as volatile as Nifty
1,397.601.70% (+23.40)
1,397.601.70% (+23.40)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹14,005 cr, stock is ranked 445
Moderate RiskStock is 2.77x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹14,005 cr, stock is ranked 445
Moderate RiskStock is 2.77x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
64.9811.070.22%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.226.550.48%

Forecast & Ratings

Detailed Forecast 
75%
Analysts have suggested that investors can buy this stock

from 8 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Rainbow Children’s Medicare is engaged in the business of rendering medical and healthcare services. The Company is a multi-specialty pediatric, and obstetrics and gynecology hospitals.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 19.34%, vs industry avg of 10.02%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.5% to 2.16%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 37.23%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue249.12332.38411.43551.14729.74660.31992.701,204.441,333.961,381.10
Raw Materialssubtract39.7751.6259.9980.21105.31103.26194.73158.28165.28905.04
Power & Fuel Costsubtract6.278.279.3312.3514.8613.8416.8121.2326.61
Employee Costsubtract49.6669.2288.2485.74108.97102.09116.07144.06176.17
Selling & Administrative Expensessubtract86.9435.5546.36163.42216.79202.80266.74350.68395.99
Operating & Other expensessubtract21.33101.69128.5149.6272.7762.9171.5799.76100.49
Depreciation/Amortizationsubtract18.3921.8928.0860.3269.4173.3483.2690.27112.08120.90
Interest & Other Itemssubtract3.132.904.2741.9648.2646.3756.1758.3962.5362.61
Taxes & Other Itemssubtract6.709.9010.3912.9337.6315.6849.0870.9477.8277.00
EPS2.284.224.475.076.344.5515.2021.5621.3821.24
DPS0.250.310.500.501.000.002.003.003.000.00
Payout ratio0.110.070.110.100.160.000.130.140.140.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 27PDF
FY 2023

Annual report

PDF

Investor Presentation

May 14PDF
Feb 9PDF
Nov 3PDF
+2 more
FY 2024

Annual report

PDF

Investor Presentation

Aug 7PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Rainbow Children's Medicare Ltd64.5411.070.22%
Apollo Hospitals Enterprise Ltd108.3813.300.24%
Max Healthcare Institute Ltd85.1510.710.16%
Fortis Healthcare Ltd73.295.130.17%

Price Comparison

Compare RAINBOW with any stock or ETF
Compare RAINBOW with any stock or ETF
RAINBOW
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding49.88%9.80%4.01%24.78%11.54%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun19.82%20.19%21.63%22.32%24.04%24.78%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Rainbow Children's Medicare Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
DSP Small Cap Fund - Growth - Direct Plan

Growth
1.2099%1.02%0.00%39/83 (-4)
Axis Flexi Cap Fund - Growth - Direct Plan

Growth
0.9316%1.00%-0.01%38/64 (+7)
DSP Flexi Cap Fund - Growth - Direct Plan

Growth
0.9162%1.06%-0.05%56/65 (-3)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 23, 2024

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Jul 23, 2024

Cash Dividend

Ex DateEx DateJun 22, 2023

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Jun 22, 2023

Cash Dividend

Ex DateEx DateSep 7, 2022

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 7, 2022

News & Opinions
Corporate
Rainbow Childrens Medicare allots 5,986 equity shares under ESOP

Rainbow Childrens Medicare has allotted 5,986 equity shares under ESOP on 22 August 2024. With this allotment, the paid up equity share capital of the company has increased to 10,15,51,673 equity shares of Rs 10 each. Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Rainbow Medicare Q1 PAT slides 4% YoY; ARPOB at Rs 56,212

Revenue from operations increased 15% year on year (YoY) to Rs 330.22 crore in the quarter ended 30 June 2024. Total expenses rose by 20.64% YoY to Rs 288.79 crore in the first quarter, primarily due to higher cost of materials consumed (up 10.63% YoY), employee benefit expense (up 12.39% YoY), higher finance cost (up 24.3% YoY) and higher professional fees to doctor (up 21.65% YoY). Profit before tax for the quarter stood at Rs 53.35 crore, down by 4.08% from Rs 55.62 crore in same quarter last year. For Q1 FY25, EBITDA grew 6.9% YoY to Rs 93.72 crore and EBITDA margin reduced to 28.4% from 30.5% posted in Q1 FY24. For the June 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 42.4% (up 151 bps YoY). Average revenue per occupied bed (ARPOB) was Rs 56,212 (down 6% YoY) and average length of stay (ALOS) was 2.76 days (up 11% YoY) during the period under review. On the operational front, the company achieved a robust 15% revenue growth, reflecting our successful operational strategies and market positioning. Despite the traditionally slower summer period, our performance underscores the strength and resilience of our business model. While EBITDA growth was moderated due to the initial costs associated with our new facilities, we are confident in the long-term value of these investments. The firm continued to maintain a robust balance sheet and have cash & cash equivalent, fixed deposits and mutual fund investments aggregating to Rs 518 crore as of 30 June 2024. These funds will support ongoing capital expenditure plans. With the current cash flow and anticipated internal accruals in coming quarters, the company is well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds. During the quarter, the company invested Rs 56.7 crore in capital expenditures towards expanding and enhancing our facilities. Dr. Ramesh Kancharla, chairman & managing director, said, 'I am delighted to share that we have delivered a strong performance this quarter. Although our PAT for Q1 FY25 was Rs. 397 Mn, a decrease of 4.2% from Rs. 415 Mn in Q1 FY24, this is attributable to the initial costs associated with our new hospitals. We currently have 2000+ beds including the managed beds, with a right mix of matured and new beds. Our focus remains to drive occupancies and optimize operations across the group along with custromer delight. We are confident in our ability to drive growth in the upcoming quarters.' Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 4 clinics in 6 cities, with a total bed capacity of 1,935 beds. The scrip rose 1.61% to currently trade at Rs 1,222.40 on the BSE. Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Rainbow Children's Medicare consolidated net profit declines 3.59% in the June 2024 quarter

Net profit of Rainbow Children's Medicare declined 3.59% to Rs 39.53 crore in the quarter ended June 2024 as against Rs 41.00 crore during the previous quarter ended June 2023. Sales rose 14.99% to Rs 330.22 crore in the quarter ended June 2024 as against Rs 287.17 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales330.22287.17 15 OPM %28.3830.54 - PBDT87.5080.95 8 PBT53.3555.62 -4 NP39.5341.00 -4 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Rainbow Childrens Medicare to hold board meeting

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live